FP7
ENABLE
European Gram Negative Antibacterial Engine
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 72 months
- Total cost
- EUR 100,832,798
- EU contribution
- EUR 58,900,000
- Participants
- 47 from 13 countries
- Topic
- FP7_IMI-JU-08-2012-02-01
- Grant agreement
- 115583
Coordinated by Glaxosmithkline Research & Development Limited (GBUnited Kingdom).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Coordinator | Not stated | PIC (1.00) |
| Asclepia Outsourcing Solutions | BEBelgium | Participant | EUR 610,400 | PIC (1.00) |
| European Biotechnology Network aisbl | BEBelgium | Participant | EUR 285,240 | PIC (1.00) |
| Universite de Liege | BEBelgium | Participant | EUR 27,580 | known name (0.95) |
| Basilea Pharmaceutica International AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Juvabis AG | CHSwitzerland | Participant | EUR 726,405 | PIC (1.00) |
| Universitat Zurich | CHSwitzerland | Participant | EUR 1,985,780 | known name (0.95) |
| Bioresources Technology & Engineering GmbH | DEGermany | Participant | EUR 86,580 | PIC (1.00) |
| Forschungszentrum Borstel Leibniz Lungenzentrum | DEGermany | Participant | EUR 567,678 | known name (0.95) |
| Helmholtz-Zentrum Fur Infektionsforschung GmbH | DEGermany | Participant | EUR 448,562 | known name (0.97) |
| MPS Hamburg GmbH | DEGermany | Participant | Not stated | PIC (1.00) |
| Kobenhavns Universitet | DKDenmark | Participant | EUR 1,938,693 | known name (0.95) |
| Region Hovedstaden | DKDenmark | Participant | EUR 1,011,953 | known name (0.95) |
| Statens Serum Institut | DKDenmark | Participant | EUR 962,561 | known name (0.95) |
| Biomol-Informatics SL | ESSpain | Participant | Not stated | PIC (1.00) |
| Fundacion Centro de Excelencia en Investigacion de Medicamentos Innovadores en Andalucia | ESSpain | Participant | EUR 215,775 | VAT number (0.97) |
| Servicio Madrileno de Salud | ESSpain | Participant | EUR 586,800 | known name (0.97) |
| Universitat de Barcelona | ESSpain | Participant | EUR 44,340 | known name (0.97) |
| Helsingin Yliopisto | FIFinland | Participant | EUR 1,030,230 | known name (0.95) |
| Northern Antibiotics Oy | FIFinland | Participant | EUR 115,994 | PIC (1.00) |
| Centre National de la Recherche Scientifique Cnrs | FRFrance | Participant | EUR 364,224 | known name (0.95) |
| Mutabilis | FRFrance | Participant | EUR 3,408,564 | PIC (1.00) |
| Nosopharm | FRFrance | Participant | EUR 1,150,090 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | Not stated | PIC (1.00) |
| Aston University | GBUnited Kingdom | Participant | EUR 240,646 | known name (0.95) |
| Cardiff University | GBUnited Kingdom | Participant | EUR 1,275,588 | known name (0.95) |
| Helperby Therapeutics Ltd | GBUnited Kingdom | Participant | EUR 104,120 | PIC (1.00) |
| Inspiralis Ltd | GBUnited Kingdom | Participant | EUR 207,168 | PIC (1.00) |
| John Innes Centre | GBUnited Kingdom | Participant | EUR 351,120 | known name (0.95) |
| Molecular Discovery Ltd | GBUnited Kingdom | Participant | EUR 455,910 | PIC (1.00) |
| Redx Pharma Ltd | GBUnited Kingdom | Participant | EUR 583,724 | PIC (1.00) |
| Spero Europe Limited | GBUnited Kingdom | Participant | EUR 41,460 | PIC (1.00) |
| St George's Hospital Medical School | GBUnited Kingdom | Participant | EUR 92,200 | PIC (1.00) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 2,955,788 | PIC (1.00) |
| The Research Network Ltd. | GBUnited Kingdom | Participant | EUR 277,085 | PIC (1.00) |
| The University Court of the University of St Andrews | GBUnited Kingdom | Participant | EUR 15,764 | PIC (1.00) |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | ITItaly | Participant | EUR 54,953 | PIC (1.00) |
| Latvijas Organiskas Sintezes Instituts | LVLatvia | Participant | EUR 5,904,839 | known name (0.95) |
| Stichting Vu | NLNetherlands | Participant | EUR 1,969,634 | known name (0.95) |
| Narodowy Instytut Lekow | PLPoland | Participant | EUR 288,000 | known name (0.97) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| Beactica Therapeutics AB | SESweden | Participant | EUR 169,699 | PIC (1.00) |
| Karolinska Institutet | SESweden | Participant | EUR 877,980 | known name (0.95) |
| KeytoLead AB | SESweden | Participant | EUR 3,721 | PIC (1.00) |
| Recipharm OT Chemistry | SESweden | Participant | EUR 2,314,926 | PIC (1.00) |
| Rise Research Institutes of Sweden AB | SESweden | Participant | EUR 3,395,700 | known name (0.95) |
| Uppsala Universitet | SESweden | Participant | EUR 21,752,526 | known name (0.95) |
Changes of the consortium
First seen on with 47 participants from 13 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.